Kyle Mitchell Hocking

Principal investigator.

Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$5.1MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20182025
AwardsPatents
Federal awards as principal investigator

9 awards · $5.1M

DateAgencyAwardAmountCompany
Sep 24, 2025NIHSBIR Phase II
Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
$176KVOLUMETRIX, LLC
Aug 13, 2025NIHSBIR Phase II
Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
$1.0MVOLUMETRIX, LLC
Apr 11, 2024NIHSBIR Phase II
Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
$176KVOLUMETRIX, LLC
Apr 8, 2024NIHSBIR Phase II
Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
$1.0MVOLUMETRIX, LLC
Dec 18, 2023NIHSBIR Phase II
Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
$45KVOLUMETRIX, LLC
Mar 1, 2023NIHSBIR Phase II
Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
$1.0MVOLUMETRIX, LLC
Apr 2, 2020NIHSBIR Phase II
Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
$768KVOLUMETRIX, LLC
Mar 13, 2019NIHSBIR Phase II
Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
$804KVOLUMETRIX, LLC
Aug 21, 2018NIHSBIR Phase II
Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF)
$176KVOLUMETRIX, LLC
Among 4,795 researchers in Medtech

Peer ranks

Federal funding#272
Awards as PI#166
Patents#505
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.